Previous Next
Mood and psychotic disorders affect millions of people worldwide, profoundly impacting patients' quality of life. Despite advances in treatment, the underlying biological mechanisms remain largely misunderstood, posing significant challenges for clinical management. However, a central concept has emerged to link these conditions: functional brain dysconnectivity, a disruption in the interactions between brain regions. Studying these anomalies could pave the way for a better understanding of psychiatric disorders.

This article explores the methods used to analyze dysconnectivity and their clinical implications.

Brain Dysconnectivity: A New Biomarker for Psychiatric Disorders?

Researchers utilized functional magnetic resonance imaging (fMRI) to analyze connectivity between brain regions, comparing neural activity in patients with psychiatric disorders to that of healthy subjects. Artificial intelligence algorithms were also employed to detect patterns invisible to the human eye, enhancing the precision of these analyses.

The results reveal hyperconnectivity in the default mode network, associated with mood disorders, and hypoconnectivity in frontoparietal networks, correlated with psychosis. A correlation was also established between symptom severity and the degree of dysconnectivity.

These findings suggest that brain dysconnectivity could become a key biomarker for diagnosing and stratifying patients.

Functional Brain Dysconnectivity: toward personalized stratification of psychiatric disorders

This study offers the potential to identify new biomarkers, which will facilitate the understanding and stratification of psychiatric disorders. Beyond illuminating the mechanisms underlying psychiatric disorders, these advancements pave the way for more personalized care. By linking brain connectivity data to targeted treatments, such as behavioral therapies or neurostimulation, it becomes possible to propose interventions tailored to the specific needs of each patient.  

Source(s) :
Grot, S., et al. (2024). Label-based meta-analysis of functional brain dysconnectivity across mood and psychotic disorders. Progress in neuro-psychopharmacology & biological psychiatry, 131, 110950. ;

Last press reviews


COVID-19 and coagulation parameters: a link to mortality?

The COVID-19 pandemic, caused by SARS-CoV-2, has led to millions of deaths...

Resistance training and Multiple Sclerosis: a solution to improve function and quality of life?

Multiple sclerosis (MS) is a chronic autoimmune disease of the central ner...

Endometriosis: the Impact of hormones, sexual practice, and surgical treatments

Endometriosis is a chronic inflammatory disease modulated by estrogen leve...